CLINICAL_TRIALS trial_result · 2025-03-18

Clinical Trial Update: A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder [Phase 2]

A Phase 2 trial evaluating BNC210 for acute treatment of Social Anxiety Disorder has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bionomics Limited | Conditions: Social Anxiety Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-03-18